Jedel Elizabeth, Carlsson Jane, Stener-Victorin Elisabet
Faculty of Health and Caring Sciences, Institute of Occupational and Physical Therapy, Sahlgrenska Academy at Göteborg University, SE-40530 Göteborg, Sweden.
Eur J Pain. 2007 Jul;11(5):557-63. doi: 10.1016/j.ejpain.2006.07.007. Epub 2006 Aug 28.
Temporomandibular disorders (TMDs) occurs frequently in children and measuring health-related quality of life (HRQL) can complement efficacy measures, offering a complete picture of the impact of disease and treatment on overall well-being.
To compare HRQL, pain threshold (PT) and range of motion (ROM) in child patients with temporomandibular disorder (TMD) pain and an age and gender matched control group.
The study design was a controlled cross-sectional study. Forty-two children participated in the study. Twenty-one child patients referred to a dental pediatric clinic for specialist treatment because of TMD pain and an age and gender matched control group completed the Child health questionnaire-child form 87 (CHQ-CF87). PT was measured with Pain matcher and ROM in terms of maximum unassisted mandibular opening was measured with a ruler.
The child patients with pain more than once a week had a pain duration ranging from 3 months to almost 6 years. The median for pain intensity measured with visual analogue scale (VAS) was 47 ranging from 5 to 80 and the median for behavioral rating scale (BRS) was 3 ranging from 1 to 4. Child patients with TMD pain more than once a week reported significantly lower scores in CHQ-CF87 when compared with a control group. The results for PT and ROM were non-significant.
CHQ-CF87 could be used for measuring health and to evaluate the efficacy of treatment in child patients with TMD pain.
颞下颌关节紊乱病（TMD）在儿童中频繁发生，测量与健康相关的生活质量（HRQL）可以补充疗效指标，全面反映疾病和治疗对整体健康的影响。
比较患有颞下颌关节紊乱病（TMD）疼痛的儿童患者与年龄和性别匹配的对照组在健康相关生活质量（HRQL）、疼痛阈值（PT）和活动范围（ROM）方面的差异。
本研究设计为对照横断面研究。42名儿童参与了该研究。21名因TMD疼痛转诊至儿童牙科诊所接受专科治疗的儿童患者以及一个年龄和性别匹配的对照组完成了儿童健康问卷-儿童版87（CHQ-CF87）。使用疼痛匹配仪测量疼痛阈值（PT），用直尺测量最大自主下颌开口度来评估活动范围（ROM）。
每周疼痛超过一次的儿童患者疼痛持续时间为3个月至近6年。用视觉模拟量表（VAS）测量的疼痛强度中位数为47（范围为5至80），行为评定量表（BRS）的中位数为3（范围为1至4）。与对照组相比，每周疼痛超过一次的TMD疼痛儿童患者在CHQ-CF87中的得分显著更低。疼痛阈值（PT）和活动范围（ROM）的结果无显著差异。
CHQ-CF87可用于测量患有TMD疼痛的儿童患者的健康状况并评估治疗效果。
